Valosin-containing protein

WojciK, C., Yano, M., and DeMartino, G. N. RNA interference of valosin-containing protein (VCP/ p97) reveals multiple cellular roles linked to ubiquitin/ proteasome-dependent proteolysis. J Cell Sd 2004, 117, 281-92. 

Dai, R. M. and Li, C.-C. H. Valosin-containing protein is a multi-ubiquitin chain-targeting factor required in ubiquitin-proteasome degradation. 

Shi, J., Dixon, R., Gonzales, R., Kjellbom, P. and Bhattacharyya, M. (1995) Identifica-ton of cDNA clones encoding valosin-containing protein and other plant plasma membrane-associated proteins by a general immunoscreening strategy. Proc. Natl. Acad. Sci. USA, 92,4457-61. 

Doss-Pepe, E.W., Stenroos, E.S., Johnson, W.G. and Madura, K. (2003) Ataxin-3 interactions with rad23 and valosin-containing protein and its associations with ubiquitin chains and the proteasome are consistent with a role in ubiquitin-mediated proteolysis. Mol. Cell Biol. 28, 6469-6483. 

Y, Osada, H., and Imoto, M. (2012) Xanthohumol impairs autophagosome maturation through direct inhibition of valosin-containing protein. ACS Chem. Biol, 7, 892-900. 

Watts GD, Wymer J, Kovach Ml et al. (2004) Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet 36, 377-381. 

Schroder R, Watts GD, Mehta SG et al. (2005) Mutant valosin-containing protein causes a novel type of frontotemporal dementia. Ann Neurol 57(3), 457 61. 

Forman MS, Mackenzie IR, Cairns NJ et al. (2006) Novel ubiquitin neuropathology in frontotemporal dementia with valosin-containing protein gene mutations. J Neuropathol Exp Neurol 65(6), 571-581. 

Weihl CC, Pestronk A, Kimonis VE. (2009) Valosin-containing protein disease inclusion body myopathy with Paget s disease of the bone and fronto-temporal dementia. NeuromusculDisord 19(5), 308-315. 

Guyant-Marechal L, Laquerriere A, Duyckaerts C et al. (2006) Valosin-containing protein gene mutations clinical and neuropathologic features. Neurology 67(4), 644-651. 

Dai RM, Chen E,LongoDLetal. (1998) Involvement of valosin-containing protein, an ATPase Co-purified... 

DeLaBarre B, Brunger AT. (2003) Complete structure of p97/valosin-containing protein reveals communication between nucleotide domains. Nat Struct Die/10(10), 856-863. 

Ishigaki S, Hishikawa N, Niwa J et al. (2004) Physical and functional interaction between Dorfin and Valosin-containing protein that are colocalized in ubiquitylated inclusions in neurodegenerative disorders. JBiol chem 279(49), 51376-51385. 

Wojcik C, Rowicka M, Kudlicki A et al. (2006) Valosin-containing protein (p97) is a regulator of ER stress and of the degradation of N-end rule and ubiquitin-fusion degradation pathway substrates in mammalian cells. Mol Biol Cell 17(11), 4606-4618. 

Kitami MI, Kitami T, Nagahama M et al. (2006) Dominant-negative effect of mutant valosin-containing protein in aggresome formation. FEES Lett 580(2), 474-478. 

Mimnaugh BG, Xu W, Vos M et al. (2006) Endoplasmic reticulum vacuolization and valosin-containing protein relocalization result from simultaneous hsp90 inhibition by geldanamycin and proteasome inhibition by velcade. Mol Cancer Resi(9), 667-681. 

Lass A, McConnell E, Nowis D et al. (2007) A novel function of VCP (valosin-containing protein p97) in the control of N-glycosylation of proteins in the endoplasmic reticulum. Arch Biochem Biophys 462 (1), 62-73. 

Yamamoto S, Tomita Y, Hoshida Y et al. (2004) Expression level of valosin-containing protein (p97) is associated with prognosis of esophageal carcinoma. Clin Cancer Res 10(16), 5558-5565. 

Zhong X, Shen Y, Ballar P et al. (2004) AAA ATPase p97/valosin-containing protein interacts with gp78, a ubiquitin ligase for endoplasmic reticulum-associated degradation. JB/a/Cfem 279(44), 45676-45684. 

Song C, Xiao Z, Nagashima K et al. (2008) The heavy metal cadmium induces valosin-containing protein (VCP)-mediated aggresome formation. Toxicol Appl Pharmacol 228(8), 351-363. 

Song C, Wang Q, Li CC. (2007) Characterization of the aggregation-prevention activity of p97/ valosin-containing protein. Biochemistry 46(51), 14889-14898. 

Lucas GJ, Mehta SG, Hocking U et al. (2006) Evaluation of the role of Valosin-containing protein in the pathogenesis of familial and sporadic Paget s disease of bone. Bone 38(2), 280-285. 

Stojkovic T, Hammouda H, Richard P et al. (2009) Clinical outcome in 19 French and Spanish patients with valosin-containing protein myopathy associated with Paget s disease of bone and frontotemporal dementia. Neuromuscul Disord 19(5), 316-323. 

Vesa J, Su H, Watts GD et al. (2009) Valosin containing protein associated inclusion body myopathy abnormal vacuolization, autophagy and cell fusion in myoblasts. Neuromuscul Disord 19(11), IbG-ni. 

---